How do companies forecast when competitors will enter the market and what role does external counsel play in shaping that view? This session explores how brand and biosimilar teams, alongside their advisors, assess patent strength, injunction likelihood, settlement dynamics and litigation risk to inform launch timing and competitive positioning.